We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Investigator Gets Warning for Lapsed IRB Approval
Investigator Gets Warning for Lapsed IRB Approval
January 6, 2010
A clinical investigator has received a warning letter from the FDA for not properly randomizing trial subjects and for performing research activities after approval by the IRB had expired.